BDBM120246 US8691753, 95::US8691753, 96

SMILES NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CCc1ccc(cc1)-c1cc(cs1)-c1ccccc1

InChI Key InChIKey=MMIHYNVQXYWTFM-GOTSBHOMSA-N

Data  18 KI

PDB links: 1 PDB ID matches this monomer.

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 18 hits for monomerid = 120246   

TargetMacrophage metalloelastase(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi:  1.92nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
TargetMacrophage metalloelastase(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi:  144nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
TargetNeutrophil collagenase(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi:  410nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCollagenase 3(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi:  684nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetStromelysin-2(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi:  872nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetStromelysin-2(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+3nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+3nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetStromelysin-1(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+3nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMatrilysin(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+3nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target72 kDa type IV collagenase(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+3nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target72 kDa type IV collagenase(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+3nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMatrix metalloproteinase-14 [1-20,P8S](Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+3nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCollagenase 3(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+3nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMatrix metalloproteinase-14 [1-20,P8S](Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+4nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInterstitial collagenase(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+4nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetStromelysin-1(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+4nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeutrophil collagenase(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+4nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Commissariat A L'Energie Atomique Et Aux Energies Alternatives

US Patent
LigandPNGBDBM120246(US8691753, 95 | US8691753, 96)
Affinity DataKi: >1.00E+4nMAssay Description:The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et ...More data for this Ligand-Target Pair
In DepthDetails US Patent